evaluation of liver enzymes rising in patients treated with sodium valproate (vpa)
Authors
abstract
introduction valproic acid (vpa, valproate) is an eight-branch fatty acid and varies from other antiepileptic drugs. vpa use might lead to mild to severe hepatotoxicity. the aim of this study was to investigate valproic acid impact on liver transaminases at the beginning of vpa treatment and after three and six months of it. materials and methods this study was designed as a cross sectional project in pediatrics neurology ward of a tertiary academic hospital (ghaem hospital, mashhad-northeastern iran). all children who needed valproic acid therapy alone were selected for study. liver function test was performed for them at the beginning of vpa administration, three and six months after vpa, respectively. data was analyzed by spss version 16. results 60 children with mean age of 49±28.6 months were entered the study. 37 of them were male and 23 were female. 5% (3 children) were mental retard and 11.7% (7 patients) had neurologic or developmental deficit. mean value of aspartate aminotransferase (ast), alanine transferase (alt) and alkaline phosphatase (alp) were 27, 30.8 and 30.4 and 17.4, 20.7 and 22.8 and 425, 426 and 441 at the beginning of vpa administration, three and six months after vpa, respectively. in six months of our follow up, only one child (1.7%) had elevated liver transaminases. conclusion regard to our findings and its agreement with previous researches, it is important to control adverse drug events by measuring liver transaminases during antiepilepsy treatment.
similar resources
Evaluation of Liver Enzymes Rising in Patients Treated with Sodium Valproate (VPA)
Introduction Valproic acid (VPA, Valproate) is an eight-branch fatty acid and varies from other antiepileptic drugs. VPA use might lead to mild to severe hepatotoxicity. The aim of this study was to investigate valproic acid impact on liver transaminases at the beginning of VPA treatment and after three and six months of it. Materials and Methods This study was designed as a cross sectional pro...
full textEvaluation of urinary enzymes in newborns treated with gentamicin
Objective(s): In recent years, there has been an increasing amount of study on early diagnosis of kidney injury through sensitive and specific biomarkers. We examined the practical applicability of the urinary levels of NAG (N-acetyl-β-D-glucosaminidase), AP (alkaline phosphatase), and LDH (lactate dehydrogenase) as renal dysfunction screening biomarkers in full and pre-term newborns treated wi...
full textLiver Toxicity in Rheumatoid Arthritis Patients Treated With Methotrexate
Background:Methotrexate (MTX) is one of the most commonly used disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis (RA) which can be associated with toxic effects on different organs. This study was designed to investigate the hepatotoxic effects in RA patients treated with MTX. Methods: In this cross-sectional observational study, RA patients who received standard d...
full textAcute liver impairment after sodium valproate overdose.
Liver impairment is a recognised adverse effect of long-term sodium valproate treatment, but there are few reports concerning its occurrence after acute overdose. This report describes a 36-year-old woman who deliberately ingested 32 g of sodium valproate (Epilim). Serum valproate concentration was 4370 μmol/l (630 mg/l) at 4.3 h post-ingestion (therapeutic reference range: 300-600 μmol/l), and...
full textMy Resources
Save resource for easier access later
Journal title:
international journal of pediatricsجلد ۳، شماره ۳.۲، صفحات ۶۸۵-۶۸۹
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023